HPV Vaccine and HPV-related Health Education
OtherIncreased education of HPV-related diseases and HPV vaccine
NCT Number: NCT01526551
The purpose of this study is to evaluate the impact of a school-based Human Papillomavirus (HPV) vaccination program to determine if the combination of increased disease and vaccine education coupled with the removal of barriers will positively impact the HPV vaccination uptake and completion rates among students.
Looking for future studies?
Notify Me12 year–20 year
All sexes
Interventional
Not applicable
Monticello High School, Monticello, Kentucky, United States
The purpose of this study is to evaluate the impact of a school-based HPV vaccination program. The intervention will consists of: provision of HPV vaccine information and consent forms for parents delivered in the back-to-school packets; school-nurse delivered student education; removal of barriers (scheduling, transportation and parental presence); changing of social norms; and the provision of free HPV vaccine.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Increased education of HPV-related diseases and HPV vaccine
Eliminate structural and financial barriers to being vaccinated
Other names: School based delivery of HPV vaccine
Time frame: August 2012-June 2013
Number of students who returned a parental consent form and ultimately initiated the HPV vaccine series as a result of the school-based program
Time frame: August 2012 -- June 2013
Number of students who returned a parental consent form and ultimately completed the full HPV vaccination series as a result of the school-based program
Lake Cumberland District Health Department
Other
A Study to Compare the Impact of a School Based HPV Vaccination Program on Vaccination Uptake and Completion Rates Among High School Students in Rural, Southeastern Kentucky
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06519994
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Kisumu, Kenya
View Trial DetailsNCT07418203
Human Papillomavirus
Reims, France
View Trial DetailsNCT05413811
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Westdene, Johannesburg, South Africa
View Trial DetailsNCT02236273
Human Papillomavirus
New York, United States
View Trial Details